Industry scale PHARMIG represents about 120 pharmaceutical companies employing around 18,000 people, covering roughly 95 percent of the Austrian drug market. This indicates a wide network and potential cross-selling opportunities to suppliers, service providers, and tech partners serving the pharmaceutical sector in Austria.

Policy & advocacy As a premier industry association focused on quality, supply security, and favorable regulatory conditions, PHARMIG can be a gateway to influence and access within the Austrian pharma ecosystem, enabling partnerships around compliance, quality management, and regulatory affairs outsourcing.

European reach PHARMIG operates within a broader EU transparency and lobbying context, suggesting opportunities for services related to regulatory consulting, EU compliance, lobbying intelligence, and digital solutions that support advocacy and stakeholder engagement at both national and EU levels.

Digital tooling The organization’s tech stack includes Microsoft 365, Teams, SendGrid, and other web tools, signaling openness to scalable digital engagement, CRM, marketing automation, and secure collaboration solutions to manage member communications and events.

Revenue profile Current revenue is in the low to mid single-digit millions or less, and with a large member base and high market coverage, there is potential to offer value-added services such as data analytics, market intelligence, training programs, and technology partnerships to enhance member outcomes.